Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Hims & Hers is an American telemedicine start-up that facilitates discreet online access to gender-specific and (frequently also) prescription-only medication for sensitive health problems such as impotence, skin rashes and excess weight. These are health...
— Dr. Hendrik Leber
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Hims & Hers Health, Inc.
Hims & Hers Health ($HIMS) provides direct-to-consumer digital telehealth services, offering subscription consultations and personalized treatments across dermatology, sexual health, mental wellness, and weight loss. The manager is...
The manager shorted the stock due to concerns over decelerating subscriber growth and the risk of cheaper oral GLP-1 alternatives impacting earnings estimates. They successfully covered...
More institutional theses from ACATIS Investment
Equinor ASA ($EQNR) was sold to take profits after its share price nearly doubled following tensions around the Strait of Hormuz.
Panasonic Holdings Corporation ($PCRFY) was divested after substantial gains in AI-driven data center components pushed its valuation into overvalued territory.
Coinbase Global ($COIN) operates a leading digital asset exchange and institutional infrastructure ecosystem providing trading, custody, and staking services for cryptocurrencies. The investment manager...